Diabetes and cataract are both age-related diseases. The median age that a patient undergoes cataract surgery in the United States is now approximately 69 years, having just recently dipped under 70 years. According to the most recent National Health a…
Fellow-eye postoperative anterior chamber depth measurements taken 1 month after cataract surgery predicted refractive outcomes better than measurements taken at 1 day, according to a study.Anterior chamber depth prediction error is the primary source …
Laser treatment of eyes that have developed drug tolerance to anti-VEGF inhibitors restores drug sensitivity safely and effectively in patients with AMD. Medscape Medical News
Status: Not yet recruiting,
Condition Summary: Eye Disease
VIENNA — Six-month results of the Genentech-sponsored ROTATE trial showed benefits of switching to ranibizumab 0.3 mg in patients with diabetic macular edema after recent, frequent and long-term treatment with bevacizumab. “Switching from Avastin to Lucentis in DME and other macular diseases is a common clinical scenario. However, prospective evaluations of DME switchers studies are usually not robust and usually have significant anti-VEGF washout periods,” Dennis Marcus, MD, said at the American Society of Retina Specialists meeting.
VIENNA — Five-year follow-up of patients with VisionCare’s Implantable Miniature Telescope shows significant visual improvement, few complications and long-term patient satisfaction, according to a presenter.The implant can be surgically implanted in patients with end-stage age-related macular degeneration undergoing cataract surgery and provides 2.7 magnification.